Literature DB >> 16622650

Alimentary mucositis: putting the guidelines into practice.

Michael T Brennan1, Inger von Bültzingslöwen, Mark M Schubert, Dorothy Keefe.   

Abstract

BACKGROUND: The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology completed an evidence-based review of the literature for the management of alimentary mucositis. DISCUSSION: The present manuscript puts these guidelines into clinical practice by presenting two cases of alimentary mucositis from cancer therapy. These cases illustrate the impact of oral and gastrointestinal mucositis on patient care.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16622650     DOI： 10.1007/s00520-006-0054-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


  11 in total

1.  Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients.

Authors: 
Journal:  JPEN J Parenter Enteral Nutr       Date:  2002 Jan-Feb       Impact factor: 4.016

2.  Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.

Authors:  S Sartori; L Trevisani; I Nielsen; D Tassinari; I Panzini; V Abbasciano
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

3.  Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.

Authors:  S T Sonis; G Oster; H Fuchs; L Bellm; W Z Bradford; J Edelsberg; V Hayden; J Eilers; J B Epstein; F G LeVeque; C Miller; D E Peterson; M M Schubert; F K Spijkervet; M Horowitz
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

4.  Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care.

Authors:  B Borowski; E Benhamou; J L Pico; A Laplanche; J P Margainaud; M Hayat
Journal:  Eur J Cancer B Oral Oncol       Date:  1994

5.  Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

Authors:  Al B Benson; Jaffer A Ajani; Robert B Catalano; Constance Engelking; Steven M Kornblau; James A Martenson; Richard McCallum; Edith P Mitchell; Thomas M O'Dorisio; Everett E Vokes; Scott Wadler
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

Review 6.  Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.

Authors:  Stephen T Sonis; Linda S Elting; Dorothy Keefe; Douglas E Peterson; Mark Schubert; Martin Hauer-Jensen; B Nebiyou Bekele; Judith Raber-Durlacher; J Peter Donnelly; Edward B Rubenstein
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

7.  Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors:  Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

8.  The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.

Authors:  Linda S Elting; Catherine Cooksley; Mark Chambers; Scott B Cantor; Ellen Manzullo; Edward B Rubenstein
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

9.  Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study.

Authors:  S Sartori; L Trevisani; I Nielsen; D Tassinari; V Abbasciano
Journal:  Cancer       Date:  1996-10-01       Impact factor: 6.860

Review 10.  Nutritional support in cancer patients.

Authors:  Rafael Barrera
Journal:  JPEN J Parenter Enteral Nutr       Date:  2002 Sep-Oct       Impact factor: 4.016
View more
  5 in total

Review 1.  Mucositis guidelines: what have they achieved, and where to from here?

Authors:  Dorothy M K Keefe
Journal:  Support Care Cancer       Date:  2006-03-30       Impact factor: 3.603

2.  The MASCC/ISOO Mucositis Guidelines Update: introduction to the first set of articles.

Authors:  Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2012-11-17       Impact factor: 3.603

Review 3.  Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review.

Authors:  Christine B Boers-Doets; Joel B Epstein; Judith E Raber-Durlacher; Jan Ouwerkerk; Richard M Logan; Jan A Brakenhoff; Mario E Lacouture; Hans Gelderblom
Journal:  Oncologist       Date:  2011-12-29

Review 4.  Supportive care treatment guidelines: value, limitations, and opportunities.

Authors:  Douglas E Peterson; Rene-Jean Bensadoun; Rajesh V Lalla; Deborah B McGuire
Journal:  Semin Oncol       Date:  2011-06       Impact factor: 4.929

Review 5.  Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls.

Authors:  Dorothy M Keefe; Douglas E Peterson; Mark M Schubert
Journal:  Support Care Cancer       Date:  2006-04-07       Impact factor: 3.603
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.